Ani pharmaceuticals inc (ANIP)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Licensing revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

100

-

-

-

-

Royalty revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

114

114

82

81

57

51

-

Net Revenues

49,774

47,966

51,337

54,357

52,887

57,122

50,703

47,268

46,483

47,286

48,164

44,764

36,628

38,205

38,525

31,337

20,555

18,035

19,972

19,516

18,799

21,037

17,387

6,647

10,899

10,532

7,836

6,152

5,562

10,034

5,036

5,186

114

114

182

81

57

51

-

Operating Expenses:
Cost of sales (excluding depreciation and amortization)

21,804

17,795

15,002

15,632

14,725

20,133

15,605

16,593

20,693

20,446

21,078

21,122

16,386

16,906

16,669

11,795

3,410

3,540

3,260

3,141

2,751

3,673

3,061

2,117

2,622

2,685

2,710

2,171

2,408

-

2,321

2,118

-

-

-

-

-

-

-

Salaries and benefits

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,291

1,128

-

-

-

-

-

-

-

Freight

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

80

88

-

-

-

-

-

-

-

Research and development

6,344

4,678

4,982

5,773

4,373

3,482

4,667

5,137

2,102

2,651

2,634

2,167

1,618

135

1,041

764

966

661

815

995

403

568

883

851

376

525

454

437

296

-4,383

148

209

5,183

6,701

11,500

11,116

14,864

9,716

8,657

Selling, general, and administrative

13,683

14,014

14,357

14,188

13,284

13,376

11,769

9,962

8,956

8,885

8,022

7,380

7,293

7,369

6,928

7,628

5,904

5,455

5,399

5,551

4,751

4,742

4,057

5,433

3,703

3,426

3,480

7,172

2,310

5,518

1,256

914

1,831

1,723

1,675

1,989

1,593

1,534

1,540

Depreciation and amortization

11,183

9,564

9,473

9,472

16,103

8,686

8,548

8,313

8,195

7,022

7,099

7,101

6,706

5,812

5,966

5,956

4,609

2,111

2,047

1,415

1,327

1,282

1,187

706

703

436

382

147

145

251

143

140

30

30

35

40

41

41

42

Cortrophin pre-launch charges

4,602

-

195

-

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total Operating Expenses

57,616

52,637

44,009

45,065

48,485

45,677

40,589

40,005

39,946

39,907

38,833

37,770

32,003

36,907

30,604

26,143

14,889

11,767

11,521

11,102

9,232

10,265

9,188

9,107

7,404

7,072

7,026

9,927

5,159

3,523

5,243

4,600

7,045

8,505

13,210

13,145

16,499

11,291

10,240

Operating (Loss)/Income

-7,842

-4,671

7,328

9,292

4,402

11,445

10,114

7,263

6,537

7,379

9,331

6,994

4,625

1,298

7,921

5,194

5,666

6,268

8,451

8,414

9,567

10,772

8,199

-2,460

3,495

3,460

810

-3,775

403

-

-207

586

-

-

-

-

-

-

-

Other Expense, net
Interest expense, net

-2,032

-2,870

-3,336

-3,406

-3,354

-3,626

-3,768

-3,730

-3,634

-3,026

-3,052

-3,025

-2,932

-2,859

-2,856

-2,830

-2,782

-2,768

-2,766

-2,749

-2,725

-800

10

3

0

-186

0

-374

93

620

81

501

124

165

172

172

172

172

172

Convertible note fair value adjustment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-3,210

1,905

463

-1,753

-639

103

-381

Investment impairment charge

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

286

-

Other income /(expense), net

10

-111

-33

46

-130

-479

20

-30

-61

-3

95

-19

-18

-43

-21

-12

2

1

-28

0

68

88

82

-39

29

31

148

-434

-50

-

-91

-50

-

-

-

-

-

-

-

(Loss)/Income Before Benefit/(Provision) for Income Taxes

-9,864

-7,652

3,959

5,932

918

7,340

6,366

3,503

2,842

4,350

6,374

3,950

1,675

-1,604

5,044

2,352

2,886

3,501

5,657

5,665

6,910

10,060

8,291

-2,496

3,524

3,491

958

-4,583

260

-

-379

35

-

-

-12,733

-

-

-

-

Benefit/(provision) for income taxes

-2,900

-2,817

64

-653

469

1,910

1,329

726

592

13,979

1,654

1,269

523

-524

2,501

1,227

1,540

625

1,098

2,094

2,541

-10,945

1,545

-133

165

103

-83

0

0

-

0

0

-

-

-

-

-

-

-

Net Income from Continuing Operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,388

1,041

-4,583

260

-

-378

35

-

-

-

-

-

-

-

Discontinued Operation
Gain on discontinued operation, net of $38 provision for income taxes in the year ended December 31, 2013

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-150

-

-

-

-1

0

-

-

-

-

-

-

-

Net (Loss)/Income

-7,011

-4,835

3,895

6,585

449

5,430

5,037

2,777

2,250

-9,629

4,720

2,681

1,152

-1,080

2,543

1,125

1,346

2,876

4,559

3,571

4,369

21,005

6,746

-2,363

3,359

3,433

1,191

-4,583

260

-

-377

35

-

-

-

-

-

-

-

Net Income from Continuing Operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,388

1,041

-4,583

260

-

-378

35

-

-

-

-

-

-

-

Preferred stock dividends

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

0

2,370

2,604

-

2,527

1,139

-

-

-

-

-

-

-

Income/(Loss) from Continuing Operations Attributable to Common Stockholders and Participating Securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-6,953

-2,344

5,778

-2,906

-1,103

-10,264

-6,648

-12,733

-14,975

-17,250

-

-

Other income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2

13

-

-

-

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

1

1

1

3

-

-

Continuing operations (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.11

-

-

-

-

-

-

-

-

-

-

-

-

Discontinued operation (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.02

-

-

-

-

-

-

-

-

-

-

-

-

Basic (Loss)/Earnings Per Share

-0.59

-0.40

0.32

0.55

0.04

0.45

0.43

0.24

0.19

-0.83

0.41

0.23

0.10

-0.10

0.22

0.10

0.12

0.25

0.40

0.31

0.38

1.90

0.59

-0.21

0.33

4.98

0.13

-6.03

0.00

-

-

-

-

-

-

-

-

-

-0.17

Continuing operations (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.11

-

-

-

-

-

-

-

-

-

-

-

-

Discontinued operation (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.02

-

-

-

-

-

-

-

-

-

-

-

-

Diluted (Loss)/Earnings Per Share

-0.59

-0.39

0.32

0.53

0.04

0.46

0.42

0.23

0.19

-0.82

0.40

0.23

0.10

-0.10

0.22

0.10

0.12

0.24

0.39

0.31

0.38

1.88

0.59

-0.21

0.33

4.98

0.13

-6.03

0.00

-

-

-

-

-

-

-

-

-

-0.17

Weighted average number of common and common equivalent shares outstanding:
Basic Weighted-Average Shares Outstanding

11,902

11,887

11,879

11,851

11,747

11,734

11,706

11,679

11,589

11,562

11,553

11,546

11,527

11,518

11,465

11,402

11,395

11,426

11,384

11,344

11,326

11,305

11,235

11,233

9,991

-10,612

9,480

1,153

0

-

-

-

-

-52,244

17,406

15,664

84,764

71,194

64,607

Diluted Weighted-Average Shares Outstanding

11,902

11,983

12,085

12,269

11,823

11,789

11,804

11,789

11,706

11,191

11,677

11,667

11,653

11,637

11,625

11,541

11,489

11,554

11,563

11,549

11,562

11,676

11,302

11,233

10,001

-10,612

9,480

1,153

0

-

-

-

-

-52,244

17,406

15,664

84,764

-

-

Continuing operations (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,295.82

-1,644.86

-

-

-

-

-

-

-

Discontinued operation (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.72

0.00

-

-

-

-

-

-

-

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5

-

NET LOSS

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-11,589

-10,794

Basic and Diluted Income/(Loss) Per Share (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,940.49

-1,295.10

-1,644.86

-0.53

-

-0.73

-0.96

-0.20

-0.16

-

Basic and Diluted Weighted-Average Shares Outstanding (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-19,380

2

0

19,377

-

-

-

-

-

-